| Hepatitis C patients | ||
---|---|---|---|
 | Pre-dose values | Post-dose values | |
 | Parameters | Median (IQR)a | Median (IQR) |
1 | Subjects | ||
 | Male (n) | 8 | 8 |
 | Female (n) | 6 | 6 |
 | Total (males + female) | 14 | 14 |
2 | Age (years) | 44 (39–50) | 44 (39–50) |
 | Gender Male (%) | 8 (57) | 8 (57) |
 | Gender Female (%) | 6 (43) | 6 (43) |
3 | Weight (kg)a | 69 (64–72) | 68 (52–70) |
4 | Height (cm) | 169 (162–171) | 169 (162–171) |
5 | BMI (kg/m2) | 24 (23–25) | 23 (22–24) |
6 | Pulse/minte | 71 (68–79) | 73 (70–77) |
7 | Temperature (°C) | 37.4 (37.2–38.3) | 37.5 (37.3–37.8) |
8 | Systolic blood pressure (mmHg) | 125 (122–131) | 120 (118–129) |
 | Diastolic blood pressure (mmHg) | 85 (80–90) | 80 (75–85) |
9 | Heamoglobin (g/L) | 142 (137–150) | 143 (138–154) |
10 | Total Leukocytes counts (109/L) | 5404 (4316–6505) | 5385 (4523–7725) |
11 | Bilirubin (μmmol/L) | 15 (11–22) | 16 (10–20) |
12 | Alanine Aminotransferase (ALT; U/L) | 68 (64–79) | 60 (53–69)b |
13 | Aspartate Aminotransferase (AST; U/L) | 56 (53–59) | 48 (45–51)b |
14 | Alaline Phosphatase (ALP; U/L) | 84 (72–91) | 77 (68–85)b |
15 | Creatinine (μmol/L) | 92 (84–109) | 85 - (74–113) |